Treace Medical Concepts (TMCI) Short term Debt (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Short term Debt came in at $3.2 million in Q2 2026, up 184.73% on a YoY basis from $1.1 million in Q2 2025, and up 78.43% quarter-over-quarter from $1.8 million in Q1 2026.
Powered by 
Analysis
Treace Medical Concepts (TMCI) Short term Debt (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has reported Short term Debt for 3 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Short term Debt rose 184.73% year-over-year to $3.2 million; the trailing twelve-month figure through Jun 2026 stood at $3.2 million (up 184.73% YoY), and the FY2025 full-year result was $1.7 million, changed N/A from the prior year.
- Short term Debt rose to $3.2 million in Q2 2026 per TMCI's latest filing, from $1.8 million in the prior quarter.
- Across five years, Short term Debt topped out at $3.2 million in Q2 2026 and bottomed at $45000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Treace Medical Concepts | 294.68 Mn | 249.06 Mn | 35.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.17 Mn |
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 45,000.00 |
| Dec 31, 2020 | 1.79 Mn |